Table 6.
Period of study | Number of patients | Overall survival (%) | Cancer specific survival (%) | Disease free interval (%) | |
---|---|---|---|---|---|
Haigh et al. (SEER) [16] | 1988–1993 | 172 | 73 | ||
Lopez-Penabad et al. [14] | 1944–1995 | 89 | 55 | 64 | |
Bhattacharyya et al. (SEER) [4] | 1973–1998 | 555 | 71.1 | ||
Stojadinovic et al. [7] | 1940–2000 | 56 | 73 | 61 | |
Kushchayeva et al. [11] | 1976–2002 | 33 | 49 | 40.5 | |
Mills et al. [8] | 1946–2003 | 62 | 64 | 43 | |
Jillard et al. (National Cancer Database) [17] | 1998–2006 | 1909 | 70.7 | ||
Nagar et al. (SEER-9) [1] | 1975–2009 | 1416 | 77.1 | ||
Goffredo et al. (SEER) [2] | 1988–2009 | 3311 | 91 | ||
Sugino et al. [10] | 1989–2010 | 73 | 93.1 | ||
Petric et al. [6] | 1972–2011 | 108 | 88 | 68 | |
Our study | 1995–2014 | 239 | 77.2 | 92.5 | 86.2 |
SEER surveillance, epidemiology, and end results